KCA
CABA icon

KVP Capital Advisors’s Cabaletta Bio CABA Stock Holding History

KVP Capital Advisors’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Hold
505,431
– – 1.15% 31
2026
Q1 		$1.36M Hold
505,431
– – 1.02% 28
2025
Q4 		$1.11M Buy
+505,431
New +$1.25M 1.07% 24

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

KVP Capital Advisors's CABA Position: Q2 2026 in Review

KVP Capital Advisors held its Cabaletta Bio (CABA) position steady in Q2 2026 at 505,431 shares worth $1.57M. The position accounts for 1.15% of the portfolio, ranked #31.

KVP Capital Advisors first reported a position in CABA in Q4 2025 and has held it in 3 quarters since. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • KVP Capital Advisors held 505,431 shares of Cabaletta Bio worth $1.57M as of Q2 2026.
  • KVP Capital Advisors left its Cabaletta Bio share count unchanged in Q2 2026.
  • Cabaletta Bio made up 1.15% of KVP Capital Advisors's portfolio in Q2 2026, its #31 holding.
  • KVP Capital Advisors first reported a position in Cabaletta Bio in Q4 2025 and has held it in 3 quarters since.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on KVP Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.